Browse > Article

Case Series of Advanced Non-Small Cell Lung Cancer Patients Treated with Hang-Am Plus  

Zheng, Hong-Mei (East-West Cancer Center, Dunsan Oriental Hospital, Dae-Jeon University)
Yoon, Jeung-Won (East-West Cancer Center, Dunsan Oriental Hospital, Dae-Jeon University)
Lee, Yeon-Weol (East-West Cancer Center, Dunsan Oriental Hospital, Dae-Jeon University)
Cho, Chong-Kwan (East-West Cancer Center, Dunsan Oriental Hospital, Dae-Jeon University)
Oh, Dal-Seok (Tumor Research Center, Korea Institute of Oriental Medicine)
Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Oriental Hospital, Dae-Jeon University)
Publication Information
The Journal of Internal Korean Medicine / v.32, no.1, 2011 , pp. 113-120 More about this Journal
Abstract
Objectives : A case series was conducted to investigate the therapeutic effects of Hang-Am Plus (HAP) on the tumor response and HRQoL (Health Related Quality of Life) in advanced non-small cell lung cancer (NSCLC) patients. Methods : Three patients were given 1,000-2,000 mg of HAP, three times a day (daily total dosage of 3,000-6,000 mg/day) for 12 weeks. Results : After the 3 month administration with HAP, three patients showed stable disease (SD) condition according to the chest computed tomography (CT), and two of the patients reported a decrease in pain levels. Conclusions : The observed NSCLC cases suggest treatment with HAP may be related to the observed tumor growth inhibition and pain reduction.
Keywords
Hang-Am Plus (HAP); Non Small Cell Lung Cancer (NSCLC); Oriental Medicine treatment; Stable Disease (SD);
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Lee HJ, Lee G, Yoo HS. Toxicological Study on Hang-Am-Plus in Mice. J Acupunct Meridian Stud. 2011;4(1):54-60.   DOI   ScienceOn
2 Park SE, Yoo HS, Jin CY, Hong SH, Lee YW, Kim BW, et al. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food Chem Toxicol. 2009;47(7):1667-75.   DOI   ScienceOn
3 Park SC, Yoo HS, Park C, Cho CK, Kim GY, Kim WJ, et al. Induction of apoptosis in human lung carcinoma cells by the water extract of Panax notoginseng is associated with the activation of caspase-3 through downregulation of Akt. Int J Oncol. 2009;35(1):121-7.
4 Kim KS, Jung TY, Yoo HS, Lee YW, Cho CK. Case Series of Advanced Non-small Cell Lung Cancer Patients Treated with Hang-Am-Plus. Korean J. Orient. Int. Med. 2009;30(4):893-900.
5 李大鹏. 康莱特注射液抗癌作用激励研究进展. Traditional Chinese Drug Research & Clinical Pharmacology. 2001;12(2):122-4.
6 Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129-39.   DOI   ScienceOn
7 Herbst RS, Sandler AB. Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab? Oncologist 2004;9 (Suppl 1):19-26.
8 Gridelli C, Maione P, Del Gaizo F, Colantuoni G, Guerriero C, Ferrara C, et al. Sorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer. Oncologist 2007;12(2):191-200.   DOI   ScienceOn
9 Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS, Choi SJ. Antitumor effect of Hang-Am-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cacner cell lines. J Kor. Oriental Med. 2009;30(5):50-60.
10 賈英杰, 史福敏, 賈彦焘, 田菲, 陳軍, 孫一予. Clinical observation on advanced non-small cell carcinoma of lung treated by Xiaoyan decoction. TIANJIN JOURNAL OF TRADITIONAL CHINESE MEDICINE. 2004;21(2):108-9.
11 Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al.: Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346(2):92-8.   DOI   ScienceOn
12 Meng ZQ, Shen YH, Yang PY, New-man R, Bei WY, Zhang Y, et al. Phase I study of huachansu in hepatocellular carcinoma, non-small cell lung cancer, and pancreatoc cancer: a preliminary report. CHINA ONCOLOGY. 2007;17(5):376-9.
13 Deng J. Clinical observations of cinobufotalin combined with gefitinib for advanced non-small cell lung cancer patients. CHINESE JOURNAL OF MODERN DRUG APPLICATION. 2007;1(11):29-30.
14 Yanf YW, Bian HM, Jiang FR. Lung Cancer and Traditional Chinese Medicine Therapy. CHINESE ARCHIVES OF TRADITIONAL CHINESE MEDICINE. 2009;27(9):1934-6.
15 周雍明, 朴炳奎, 侯炜, 林洪生, 花宝金, 熊露, 等. 肺瘤平膏改善非小细胞肺癌患者免疫状态及预后的臨床觀察. Chinese Journal of Information on TCM. 2008;15(5):78-9.
16 查名宝, 武翔, 胡琴, 陈祥. 参麦注射液合并化療治療非小细胞性肺癌的臨床觀察. ANHUI MEDICAL AND PHARMACEUTICAL JOURNAL. 2006;10(6):724-8.
17 Yoo SH, Yoo HS, Cho CK, Lee YW. A Case Report for Recurred Squamous Cell Lung Carcinoma Treated with Hang-Am-Dan: 7 years follow-up. Korean J. Orient. Int. Med. 2007;28(2):386-90.
18 Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12:20-37.   DOI   ScienceOn
19 Asamura H, Goya T, Koshiishi Y, Sohara Y, Tsuchiya R, Miyaoka E. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. J Thorac Cardiovasc Surg. 2006;132:316-9.   DOI   ScienceOn
20 Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367-80.   DOI   ScienceOn
21 Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.   DOI
22 Bang JY, Kim EY, Shim TK, Yoo HS, Lee YW, Kim YS, et al. Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B), a Korean traditional medicine, using antibody microarray chip. BioChip J. 2010;4(4):350-5.   DOI   ScienceOn
23 Available from: http://www.cancer.go.kr/cms/statics/incidence/index.html. 국가암정보센터 암발생률, 암종별 발생 현황